An Observational Study of OPTIVE PLUS® for the Treatment of Dry Eye Disease

Study Identifier
MAF/AGN/OPH/DE/012
CT.gov Identifier
NCT01711424
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Dry Eye
    • Study Drug
  • OPTIVE PLUS®
    • Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Diagnosis of dry eye * Physician decision to treat with OPTIVE PLUS® in accordance with the physician's standard practice
    Exclusion Criteria:
    * None

    Protocol Summary

    This is an observational study of OPTIVE PLUS® in patients with dry eye disease in a routine clinical setting. Treatment decisions are made by the physician and reflect the physician's current standard of care.

    Study Locations

    Location
    Status
    Location
    Stuttgart, Baden-Wurttemberg, Germany
    Status
    Not applicable